Mersana Therapeutics, Inc. MRSN 深 沪
等待开盘 02-07 09:30:00 美东时间
29.04
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 29.04
- 总市值 281.66万
- 52周最高 0.00
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.00
- 委 比 0.00%
- 总股本 9.70万
- 历史最高 0.00
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.00
- 每 手 1
- 风险率 9.43%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Dow Dips Over 400 Points; JD.com Posts Upbeat Q3 Results
U.S. stocks traded lower midway through trading, with the Nasdaq Composite fall...
2025-11-14 01:03
Mersana Therapeutics Earnings Preview
Mersana Therapeutics (NASDAQ:MRSN) is preparing to release its quarterly earnin...
2025-11-14 00:02
Day One Biopharma Expands Oncology Pipeline With $285 Million Mersana Buyout
Day One Biopharmaceuticals plans to acquire Mersana Therapeutics in a deal worth up to $285 million to expand its cancer drug portfolio.
2025-11-13 23:15
Mersana Therapeutics Reports Additional Positive Interim Phase 1 Clinical Data for Emi-Le in Oral Presentation at 2025 ASCO Annual Meeting
Mersana Therapeutics announced interim Phase 1 data for Emi-Le, a B7-H4-targeted ADC, showing strong clinical activity in cancers like TNBC and ovarian cancer, with a 31% ORR in B7-H4 high tumors and a 44% ORR in patients with ≤4 prior therapies. The trial's safety profile remains favorable.
2025-06-02 12:10
Citigroup Maintains Buy on Mersana Therapeutics, Lowers Price Target to $5
Citigroup analyst Ashiq Mubarack maintains Mersana Therapeutics (NASDAQ:MRSN) with a Buy and lowers the price target from $6 to $5.
2024-08-27 22:40
